Literature DB >> 21253226

Screening in pregnancy.

A Biringer.   

Abstract

Over the past 20 years, traditional elements of antenatal care have been supplemented by complex biochemical and biophysical investigations. With his/her knowledge of the patient and awareness of the principles of screening, the family physician is ideally placed to assess potential problems in pregnancy. This article reviews the rationale for screening for certain disorders in pregnancy. Genetic disorders, infectious diseases, and other specific conditions are considered. Some of the more recent controversies in prenatal screening are highlighted.

Entities:  

Year:  1988        PMID： 21253226      PMCID： PMC2219160     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


  30 in total

1.  A critical review of periodic health screening using specific screening criteria. Part 2: Selected endocrine, metabolic and gastrointestinal diseases.

Authors:  P S Frame; S J Carlson
Journal:  J Fam Pract       Date:  1975-04       Impact factor: 0.493

2.  Screening for maternal serum alpha-fetoprotein: what about the low side?

Authors:  A Lippman; J A Evans
Journal:  CMAJ       Date:  1987-04-15       Impact factor: 8.262

3.  Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project.

Authors:  T A Doran; G H Valentine; P Y Wong; G Wielgosz; R J Benzie; H C Soltan; M R Jenner; P A Morland; R J Montgomery; L C Allen
Journal:  CMAJ       Date:  1987-08-15       Impact factor: 8.262

4.  Maternal serum alpha-fetoprotein screening: benefits, risks, and costs.

Authors:  T L Campbell
Journal:  J Fam Pract       Date:  1987-11       Impact factor: 0.493

5.  Cost-effectiveness of prenatal screening and immunization for hepatitis B virus.

Authors:  J A Arevalo; A E Washington
Journal:  JAMA       Date:  1988-01-15       Impact factor: 56.272

Review 6.  Sepsis neonatorum.

Authors:  J D Siegel; G H McCracken
Journal:  N Engl J Med       Date:  1981-03-12       Impact factor: 91.245

7.  First-year results of routine alpha-fetoprotein testing on prenatal patients in a family practice.

Authors:  B D Weiss
Journal:  J Fam Pract       Date:  1988-03       Impact factor: 0.493

8.  Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus.

Authors:  C G Prober; P A Hensleigh; F D Boucher; L L Yasukawa; D S Au; A M Arvin
Journal:  N Engl J Med       Date:  1988-04-07       Impact factor: 91.245

9.  Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.

Authors:  M S DiMaio; A Baumgarten; R M Greenstein; H M Saal; M J Mahoney
Journal:  N Engl J Med       Date:  1987-08-06       Impact factor: 91.245

10.  Prenatal testing for maternal serum alpha-fetoprotein.

Authors:  E J Schwager; B D Weiss
Journal:  Am Fam Physician       Date:  1987-04       Impact factor: 3.292
View more
  1 in total

1.  HBV Screening during Pregnancy.

Authors:  M Steben
Journal:  Can Fam Physician       Date:  1989-03       Impact factor: 3.275
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.